
Cancer testing company Agendia to go public
Spun off from the Netherlands Cancer Institute in 2003, it provides a range of DNA testing of breast, colorectal and other cancers at labs in Amsterdam and in Irvine, California
Source: FT.com - Pharmaceuticals